{"id":"NCT01286207","sponsor":"Organon and Co","briefTitle":"Long-Term Exposure to Rizatriptan 5-mg and 10-mg Oral Tablet (Combined Extension Protocols MK-0462-022, MK-0462-025, MK-0462-029)","officialTitle":"Long-Term Exposure to Rizatriptan 5-mg and 10-mg Oral Tablet (Combined Protocols 022, 025, 029)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"1995-03","primaryCompletion":"1997-05","completion":"1997-05","firstPosted":"2011-01-31","resultsPosted":"2011-06-10","lastUpdate":"2022-02-03"},"enrollment":1959,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"SINGLE","primaryPurpose":"TREATMENT"},"conditions":["Migraine Disorders"],"interventions":[{"type":"DRUG","name":"Rizatriptan 5 mg","otherNames":["MK-0462, Maxalt"]},{"type":"DRUG","name":"Rizatriptan 10 mg","otherNames":["MK-0462, Maxalt"]},{"type":"DRUG","name":"Standard Care","otherNames":[]}],"arms":[{"label":"Rizatriptan 5 mg","type":"EXPERIMENTAL"},{"label":"Rizatriptan 10 mg","type":"EXPERIMENTAL"},{"label":"Standard Care","type":"ACTIVE_COMPARATOR"}],"summary":"This record describes pooled data for three extension studies: MK-0462-022 (NCT00897949); MK-0462-025 (NCT00899379); and MK-0462-029 (NCT00897104). These studies examined the long-term safety and efficacy of rizatriptan used for the treatment of acute migraine and migraine recurrence.","primaryOutcome":{"measure":"Percent of Patient's Headaches With Pain Relief at 2 Hours After the Initial Dose of Test Drug","timeFrame":"2 hours after initial dose of test drug","effectByArm":[{"arm":"Rizatriptan 5 mg","deltaMin":80,"sd":null},{"arm":"Rizatriptan 10 mg","deltaMin":89.5,"sd":null},{"arm":"Standard Care","deltaMin":69.6,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":2,"exclusionCount":null},"locations":{"siteCount":0,"countries":[]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":13,"n":711},"commonTop":["Nausea","Dizziness","Infection, respiratory, upper","Asthenia/fatigue","Somnolence"]}}